Bio Behavioral Health PC — research payments reported

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$30,110	1
2024	Research	$25,711	2
2023	Research	$206,420	17
2022	Research	$318,244	34
2021	Research	$16,893	4
2020	Research	$3,408	2
2019	Research	$11,000	2

Breakdown

Who paid Research payments · program years 2019–2025

ITI, Inc. $597,378 58 payments
ACADIA Pharmaceuticals Inc $14,408 4 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone As Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder $293,605 29 payments
An Open-Label Multicenter Trial to Assess the Safety and Tolerability of Lumateperone As Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder $256,770 24 payments
An Open-Label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone As Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder $30,110 1 payment
A Randomized Double-Blind Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone As Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder $16,893 4 payments
Acp-103-056 $14,408 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.